Latest Breaking News On - Prnewswire emmaus life sciences inc - Page 1 : comparemela.com

Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico

TORRANCE, Calif., Feb. 2, 2024 /PRNewswire/ Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, today announced that it has received marketing authorization from the Puerto.

Puerto ricoUnited statesUnited arab emiratesWillis leeGeorge sekulichNational center on birth defectsCommittee on addressing sickle cell diseasePuerto rico department of healthBlueprint for action national academy of sciencesPrnewswire emmaus life sciences incEmmaus life sciencesCenters for diseaseEmmaus life sciences incExchange commissionCompany contactLife sciences

Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico

Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Puerto ricoUnited statesUnited arab emiratesWillis leeGeorge sekulichExchange commissionPrnewswire emmaus life sciences incCompany contactEmmaus life sciencesCommittee on addressing sickle cell diseaseBlueprint for action national academy of sciencesPuerto rico department of healthNational center on birth defectsEmmaus life sciences incCenters for diseaseLife sciences receives marketing authorization

Emmaus Life Sciences Reports Q3 2023 Financial Results

Emmaus Life Sciences Reports Q3 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSaudi arabiaUnited arab emiratesKingdom of saudi arabiaWillis leeEmmaus life sciences incCompany contactNational center on birth defectsEmmaus life sciencesSaudi food drug authorityCenters for diseaseCommittee on addressing sickle cell diseaseBlueprint for action national academy of sciencesPrnewswire emmaus life sciences incDrug administrationLife sciences

Emmaus Life Sciences Reports Q2 2023 Financial Results

/PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,.

Saudi arabiaUnited statesUnited arab emiratesKingdom of saudi arabiaWillis leeYutaka niiharaDrug administrationExchange commission onPrnewswire emmaus life sciences incNational center on birth defectsCenters for diseaseEmmaus life sciences incCommittee on addressing sickle cell diseaseBlueprint for action national academy of sciencesEmmaus life sciencesCompany contact

Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman

/PRNewswire/ Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, today announced that it has received marketing.

United arab emiratesUnited statesSaudi arabiaKingdom of saudi arabiaYutaka niiharaWillis leeGeorge sekulichExchange commissionEmmaus life sciences incOman ministry of healthCompany contactCenters for diseaseEmmaus life sciencesGlobal commercialization of emmaus life sciences incNational center on birth defectsCommittee on addressing sickle cell disease